Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment

M Zhang, JL Luo, Q Sun, J Harber, AG Dawson… - Nature …, 2021 - nature.com
Abstract Malignant Pleural Mesothelioma (MPM) is typically diagnosed 20–50 years after
exposure to asbestos and evolves along an unknown evolutionary trajectory. To elucidate …

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

L Mangiante, N Alcala, A Sexton-Oates, A Di Genova… - Nature Genetics, 2023 - nature.com
Malignant pleural mesothelioma (MPM) is an aggressive cancer with rising incidence and
challenging clinical management. Through a large series of whole-genome sequencing …

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

R Bueno, EW Stawiski, LD Goldstein, S Durinck… - Nature …, 2016 - nature.com
Abstract We analyzed transcriptomes (n= 211), whole exomes (n= 99) and targeted exomes
(n= 103) from 216 malignant pleural mesothelioma (MPM) tumors. Using RNA-seq data, we …

Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

J Creaney, AM Patch, V Addala, SA Sneddon… - Genome Medicine, 2022 - Springer
Background Malignant pleural mesothelioma (MPM) has a poor overall survival with few
treatment options. Whole genome sequencing (WGS) combined with the immune features of …

[HTML][HTML] Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study

ML Iacono, V Monica, L Righi, F Grosso… - Journal of thoracic …, 2015 - Elsevier
Introduction Malignant pleural mesothelioma (MPM) is a rare malignant disease, and the
understanding of molecular pathogenesis has lagged behind other malignancies. Methods …

[HTML][HTML] The genetic landscape of malignant pleural mesothelioma: results from massively parallel sequencing

M Hylebos, G Van Camp, JP Van Meerbeeck… - Journal of Thoracic …, 2016 - Elsevier
Malignant pleural mesothelioma (MPM) is a rare yet aggressive tumor that is causally
associated with—mostly professional—asbestos exposure. Given the long latency between …

Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma

G Guo, J Chmielecki, C Goparaju, A Heguy, I Dolgalev… - Cancer research, 2015 - AACR
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm associated with
asbestos exposure. Although previous studies based on candidate gene approaches have …

Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling

GJ Gordon, GN Rockwell, RV Jensen… - The American journal of …, 2005 - Elsevier
Malignant pleural mesothelioma (MPM) is a highly lethal, poorly understood neoplasm that
is typically associated with asbestos exposure. We performed transcriptional profiling using …

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Y Blum, C Meiller, L Quetel, N Elarouci, M Ayadi… - Nature …, 2019 - nature.com
Malignant pleural mesothelioma (MPM) is recognized as heterogeneous based both on
histology and molecular profiling. Histology addresses inter-tumor and intra-tumor …

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

N Alcala, L Mangiante, N Le-Stang, CE Gustafson… - …, 2019 - thelancet.com
Abstract Background Malignant Pleural Mesothelioma (MPM) is an aggressive disease
related to asbestos exposure, with no effective therapeutic options. Methods We undertook …